Speaker illustration

Doctor Miklos Rohla

Bern University Hospital, Bern (Austria)

Member of:

European Society of Cardiology

Dr. Rohla is completed his specialist training in cardiology at the 3. Medical Department for Cardiology and Intensive Care Medicine at Klinik Ottakring (formerly Wilhelminenhospital) in Vienna, Austria. Currently he is an invasive attending physician at the Bern University Hospital (Inselspital) in Bern, Switzerland. His research is focused around the medical and invasive treatment of acute coronary syndromes, antithrombotic therapies in patients with coronary artery disease or atrial fibrillation, and control of risk factors such as hypertension or hyperlipidaemia. Main clinical areas of interest are interventional cardiology and intensive care medicine.

Residual stroke risk of anticoagulated patients with atrial fibrillation: PREFER in AF European registry.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Registries and cost of treatment


The HAS-BLED score for prediction of stroke and systemic embolism: insights from the PREvention oF thromboembolic events, European Registry in Atrial Fibrillation (PREFER in AF)

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation


This platform is supported by

logo Novo Nordisk